HIV-1 infectivity by lymphocytic cell lines with integrated luciferase gene. Int. J. Mol. Med., 14, 1073–1076. 34. Harada,S., Koyanagi,Y. and Yamamoto,N. (1985) Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science, 229, 563–566. 35. Sakuragi,J., Sakuragi,S. and Shioda,T. (2007) Minimal region sufﬁcient for genome dimerization in the human immunodeﬁciency virus type 1 virion and its potential roles in the early stages of viral replication. J. Virol., 81, 7985–7992. 36. Julias,J.G., Ferris,A.L., Boyer,P.L. and Hughes,S.H. (2001) Replication of phenotypically mixed human immunodeﬁciency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase. J. Virol., 75, 6537–6546. 37. Dulude,D., Theberge-Julien,G., Brakier-Gingras,L. and Heveker,N. (2008) Selection of peptides interfering with a ribosomal frameshift in the human immunodeﬁciency virus type 1. RNA, 14, 981–991. 38. Pettit,S.C., Moody,M.D., Wehbie,R.S., Kaplan,A.H., Nantermet,P.V., Klein,C.A. and Swanstrom,R. (1994) The p2 domain of human immunodeﬁciency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol., 68, 8017–8027. 39. Kaplan,A.H., Manchester,M. and Swanstrom,R. (1994) The activity of the protease of human immunodeﬁciency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efﬁciency. J. Virol., 68, 6782–6786. 40. Bukrinskaya,A.G. (2004) HIV-1 assembly and maturation. Arch. Virol., 149, 1067–1082. 41. Peng,C., Ho,B.K., Chang,T.W. and Chang,N.T. (1989) Role of human immunodeﬁciency virus type 1-speciﬁc protease in core protein maturation and viral infectivity. J. Virol., 63, 2550–2556. 42. Nakayama,E.E. and Shioda,T. (2010) Anti-retroviral activity of TRIM5 alpha. Rev. Med. Virol., 20, 77–92. 43. Muriaux,D., De Rocquigny,H., Roques,B.P. and Paoletti,J. (1996) NCp7 activates HIV-1Lai RNA dimerization by converting a transient loop–loop complex into a stable dimer. J. Biol. Chem., 271, 33686–33692. 44. Moore,M.D., Fu,W., Soheilian,F., Nagashima,K., Ptak,R.G., Pathak,V.K. and Hu,W.S. (2008) Suboptimal inhibition of protease activity in human immunodeﬁciency virus type 1: effects on virion morphogenesis and RNA maturation. Virology, 379, 152–160. 45. Paillart,J.C., Dettenhofer,M., Yu,X.F., Ehresmann,C., Ehresmann,B. and Marquet,R. (2004) First snapshots of the HIV-1 RNA structure in infected cells and in virions. J. Biol. Chem., 279, 48397–48403. 46. Johnson,S.F. and Telesnitsky,A. (2010) Retroviral RNA dimerization and packaging: the what, how, when, where, and why. PLoS Pathog., 6, e1001007. 47. Weiss,S., Konig,B., Morikawa,Y. and Jones,I. (1992) Recombinant HIV-1 nucleocapsid protein p15 produced as a Nucleic Acids Research, 2011, Vol. 39, No. 8 3417 fusion protein with glutathione S-transferase in Escherichia coli mediates dimerization and enhances reverse transcription of retroviral RNA. Gene, 121, 203–212. 48. Barat,C., Lullien,V., Schatz,O., Keith,G., Nugeyre,M.T., Gruninger-Leitch,F., Barre-Sinoussi,F., LeGrice,S.F. and Darlix,J.L. (1989) HIV-1 reverse transcriptase speciﬁcally interacts with the anticodon domain of its cognate primer tRNA. EMBO J., 8, 3279–3285. 49. Cruceanu,M., Urbaneja,M.A., Hixson,C.V., Johnson,D.G., Datta,S.A., Fivash,M.J., Stephen,A.G., Fisher,R.J., Gorelick,R.J., Casas-Finet,J.R. et al. (2006) Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins. Nucleic Acids Res., 34, 593–605. 50. Muriaux,D., Mirro,J., Harvin,D. and Rein,A. (2001) RNA is a structural element in retrovirus particles. Proc. Natl Acad. Sci. USA, 98, 5246–5251. 51. Rulli,S.J. Jr, Hibbert,C.S., Mirro,J., Pederson,T., Biswal,S. and Rein,A. (2007) Selective and non-selective packaging of cellular RNAs in retrovirus particles. J. Virol., 81, 6623–6631. 52. Song,R., Kafaie,J., Yang,L. and Laughrea,M. (2007) HIV-1 viral RNA is selected in the form of monomers that dimerize in a three-step protease-dependent process; the DIS of stem-loop 1 initiates viral RNA dimerization. J. Mol. Biol., 371, 1084–1098. 53. Rein,A., Henderson,L.E. and Levin,J.G. (1998) Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: signiﬁcance for viral replication. Trends Biochem. Sci., 23, 297–301. 54. Freed,E.O. (2001) HIV-1 replication. Somat Cell Mol. Genet., 26, 13–33. 55. Shvadchak,V.V., Klymchenko,A.S., de Rocquigny,H. and Mely,Y. (2009) Sensing peptide–oligonucleotide interactions by a two-color ﬂuorescence label: application to the HIV-1 nucleocapsid protein. Nucleic Acids Res., 37, e25. 56. Briggs,J.A., Johnson,M.C., Simon,M.N., Fuller,S.D. and Vogt,V.M. (2006) Cryo-electron microscopy reveals conserved and divergent features of gag packing in immature particles of Rous sarcoma virus and human immunodeﬁciency virus. J. Mol. Biol., 355, 157–168. 57. Briggs,J.A., Simon,M.N., Gross,I., Krausslich,H.G., Fuller,S.D., Vogt,V.M. and Johnson,M.C. (2004) The stoichiometry of Gag protein in HIV-1. Nat. Struct. Mol. Biol., 11, 672–675. 58. Tche´ nio,T. and Heidmann,T. (1995) The dimerization/packaging sequence is dispensable for both the formation of high-molecular-weight RNA complexes within retroviral particles and the synthesis of proviruses of normal structure. J. Virol., 69, 1079–1084. 59. Ortiz-Conde,B.A. and Hughes,S.H. (1999) Studies of the genomic RNA of leukosis viruses: implications for RNA dimerization. J. Virol., 73, 7165–7174. 60. Mirambeau,G., Lyonnais,S., Coulaud,D., Hameau,L., Lafosse,S., Jeusset,J., Borde,I., Reboud-Ravaux,M., Restle,T., Gorelick,R.J. et al. (2007) HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner. PLoS One, 2, e669.